Metformin associates lactic acidosis;Acidose lactique à la metformine

Presse Medicale

Volumn 41, Issue 10, 2012, Pages 907-916

  Montini, Florent ^a   Rondeau, Éric ^a   Peltier, Julie ^a   Mesnard, Laurent ^a   Jouzel, Charlotte ^a   Ridel, Christophe ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; LACTIC ACID; METFORMIN; RENIN INHIBITOR;

ACUTE DISEASE; AGING; DISEASE ASSOCIATION; EMERGENCY CARE; EXTRARENAL BLOOD PURIFICATION; FRAIL ELDERLY; HEART FAILURE; HUMAN; HYPOVOLEMIA; KIDNEY FAILURE; LACTATE BLOOD LEVEL; METABOLIC ACIDOSIS; METFORMIN ASSOCIATES LACTIC ACIDOSIS; MORTALITY; PRESCRIPTION; PREVALENCE; PURIFICATION; RARE DISEASE; SHORT SURVEY; TREATMENT WITHDRAWAL;

ACIDOSIS, LACTIC; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; MODELS, BIOLOGICAL; RENAL DIALYSIS;

EID: 84866355349     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.01.030     Document Type: Short Survey

References (36)

1. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998, 352(9131):854-865.
2. DeFronzo R.A., Goodman A.M. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med. 1995, 333(9):541-549.
3. Selvin E., Bolen S., Yeh H.C., Wiley C., Wilson L.M., Marinopoulos S.S., et al. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med. 2008, 168(19):2070-2080.
4. Williams R.H., Palmer J.P. Farewell to phenformin for treating diabetes mellitus. Ann Intern Med. 1975, 83(4):567-568.
5. Chan N.N., Brain H.P., Feher M.D. Metformin-associated lactic acidosis: a rare or very rare clinical entity?. Diabet Med. 1999, 16(4):273-281.
6. Chang C.T., Chen Y.C., Fang J.T., Huang C.C. Metformin-associated lactic acidosis: case reports and literature review. J Nephrol. 2002, 15(4):398-402.
7. Weil M.H., Afifi A.A. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970, 41(6):989-1001.
8. Bakker J., Gris P., Coffernils M., Kahn R.J., Vincent J.L. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996, 171(2):221-226.
9. James J.H., Luchette F.A., McCarter F.D., Fischer J.E. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 1999, 354(9177):505-508.
10. Vincent J.L., Dufaye P., Berré J., Leeman M., Degaute J.P., Kahn R.J. Serial lactate determinations during circulatory shock. Crit Care Med. 1983, 11(6):449-451.
11. Bailey C.J., Turner R.C. Metformin. N Engl J Med. 1996, 334(9):574-579.
12. Protti A., Russo R., Tagliabue P., Vecchio S., Singer M., Rudiger A., et al. Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication. Crit Care. 2010, 14(1):R22.
13. Shu Y., Brown C., Castro R.A., Shi R.J., Lin E.T., Owen R.P., et al. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther. 2008, 83(2):273-280.
14. Li Q., Liu F., Zheng T.S., Tang J.L., Lu H.J., Jia W.P. SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin. Acta Pharmacol Sin. 2010, 31(2):184-190.
15. Stang M., Wysowski D.K., Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care. 1999, 22(6):925-927.
16. Salpeter S., Greyber E., Pasternak G., Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2006, 25:CD002967.
17. Salpeter S., Greyber E., Pasternak G., Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2003, (2):CD002967.
18. Salpeter S.R., Greyber E., Pasternak G.A., Salpeter E.E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010, 14:4.
19. Bolen S., Feldman L., Vassy J., Wilson L., Yeh H.C., Marinopoulos S., et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007, 147(6):386-399.
20. Peters N., Jay N., Barraud D., Cravoisy A., Nace L., Bollaert P.E., et al. Metformin-associated lactic acidosis in an intensive care unit. Crit Care. Crit Care. 2008, 12(6):R149.
21. Seidowsky A., Nseir S., Houdret N., Fourrier F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med. 2009, 37(7):2191-2196.
22. Stades A.M., Heikens J.T., Erkelens D.W., Holleman F., Hoekstra J.B. Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med. 2004, 255(2):179-187.
23. Gras V., Bouffandeau B., Montravers P.H., Lalau J.D. Effect of metformin on survival rate in experimental sepsis. Diabetes Metab. 2006, 32(2):147-150.
24. McCormack J., Johns K., Tildesley H. Metformin's contraindications should be contraindicated. CMAJ. 2005, 173(5):502-504.
25. Akoglu H., Akan B., Piskinpasa S., Karaca O., Dede F., Erdem D., et al. Metformin-associated lactic acidosis treated with prolonged hemodialysis. Am J Emerg Med. 2011, 29(5). 575.e3-5.
26. Arieff A.I., Leach W., Park R., Lazarowitz V.C. Systemic effects of NaHCO3 in experimental lactic acidosis in dogs. Am J Physiol. 1982, 242(6):F586-F591.
27. Stacpoole P.W., Wright E.C., Baumgartner T.G., Bersin R.M., Buchalter S., Curry S.H., et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med. 1992, 327(22):1564-1569.
28. Nyirenda M.J., Sandeep T., Grant I., Price G., McKnight J.A. Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score. Diabet Med. 2006, 23(4):432-435.
29. Heaney D., Majid A., Junor B. Bicarbonate haemodialysis as a treatment of metformin overdose. Nephrol Dial Transplant. 1997, 12(5):1046-1047.
30. Panzer U., Kluge S., Kreymann G., Wolf G. Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant. 2004, 19(8):2157-2158.
31. Lalau J.D., Andrejak M., Morinière P., Coevoet B., Debussche X., Westeel P.F., et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol. 1989, 27(6):285-288.
32. Spiller H.A., Quadrani D.A. Toxic effects from metformin exposure. Ann Pharmacother. 2004, 38(5):776-780.
33. Horlen C., Malone R., Bryant B., Dennis B., Carey T., Pignone M., et al. Frequency of inappropriate metformin prescriptions. JAMA. 2002, 287(19):2504-2505.
34. Misbin R.I., Green L., Stadel B.V., Gueriguian J.L., Gubbi A., Fleming G.A. Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med. 1998, 338:265-266.
35. Salpeter S.R., Greyber E., Pasternak G.A., Salpeter E.E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med. 2003, 163(21):2594-2602.
36. Georgen S.K., Rumbold G., Compton G., Harris C. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. Radiology 2010, 254:261-269.